GlassScriptPhysician profile
Ashley Taylor
NPI 1063054955
$3,885.14
in general payments reported to CMS, 2019-2025
18 companies · $1,504 in 2025
The $1,504 reported for 2025 was more than what 88% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $278 · 2022: $436 · 2023: $1,080 · 2024: $588 · 2025: $1,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,171.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $1,126.43 | 2022-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Neurocrine Biosciences, INC. | $523.76 | 2023-2024 | Ingrezza |
| Axsome Therapeutics, INC. | $309.30 | 2023-2025 | Auvelity |
| Alkermes, INC. | $294.52 | 2021-2024 | Lybalvi, Aristada, Vivitrol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $257.19 | 2023-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $214.57 | 2025 | Fanapt |
| Abbvie INC. | $209.11 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $142.25 | 2021 | |
| Eisai INC. | $122.50 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $116.37 | 2025 | Cobenfy |
| Neurelis, INC. | $114.52 | 2025 | Valtoco |
| Alexion Pharmaceuticals, INC. | $103.61 | 2025 | |
| Urovant Sciences INC | $101.97 | 2022 | |
| Braeburn INC. | $95.33 | 2024 | Brixadi |
| Janssen Pharmaceuticals, INC | $94.26 | 2024-2025 | Invega Sustenna |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $29.95 | 2025 | Uzedy |
| Lundbeck LLC | $16.23 | 2021 | |
| Jazz Pharmaceuticals INC. | $13.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.